Pfizer And Moderna To Expand Studies Of Vaccines In 5- To 11-Year-Olds

At the request of the FDA, the vaccine makers are expanding their trials with young children, seeking to better detect very rare heart issues.At the request of the FDA, the vaccine makers are expanding their trials with young children, seeking to better detect very rare heart issues.Read More

Leave a Reply

Your email address will not be published.